학술논문
Erratum to: SD1000: High Sustained Viral Response Rate in 1361 Patients With Hepatitis C Genotypes 1, 2, 3, and 4 Using a Low-cost Fixed-dose Combination Tablet of Generic Sofosbuvir and Daclatasvir: A Multicenter Phase III Clinical Trial.
Document Type
Correction Notice
Author
Merat, Shahin; Sharifi, Amir-Houshang; Poustchi, Hossein; Hajiani, Eskandar; Gharavi, Abdolsamad; Karimi, Jalal; Mansour-Ghanaei, Fariborz; Fattahi, Mohammad-Reza; Ahmadi, Lida; Somi, Mohammad-Hossein; Kalantari, Hamid; Ghadir, Mohammad-Reza; Sheikhesmaeili, Farshad; Baniasadi, Nadieh; Sohrabi, Masoudreza; Moosavy, Seyedhamid; Ziaee, Masood; Zahedi, Mohammad-Javad; Mokhtare, Marjan; Sali, Shahnaz
Source
Subject
*DRUG tablets
*COMBINATION drug therapy
*HEPATITIS C
*ANTIVIRAL agents
*NUCLEOTIDES
*IMIDAZOLES
*GENOTYPES
*GENERIC drugs
*DRUGS
*PATIENT compliance
*THERAPEUTICS
*
*
*
*
*
*
*
*
*
*
Language
ISSN
1058-4838
Abstract
A correction is presented to the article "SD1000: High Sustained Viral Response Rate in 1361 Patients With Hepatitis C Genotypes 1, 2, 3, and 4 Using a Low-cost Fixed-dose Combination Tablet of Generic Sofosbuvir and Daclatasvir: A Multicenter Phase III Clinical Trial" which appeared in the previous issue.